News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

Mark P. Mathieu

Mark P. Mathieu is a writer and editor with PAREXEL International Corporation.

Articles by Mark P. Mathieu

A Closer Look at 1572: Interpreting the FDA's Statement of Investigator Form

ByMark P. Mathieu,Vernette J. Molloy,Douglas R. Mackintosh

September 1st 2010

Applied Clinical Trials Supplements

A new reference guide clarifies uncertainty surrounding this sometimes misunderstood document.

A Closer Look at the 1572: Interpreting the FDA's Statement of Investigator Form

ByMark P. Mathieu,Vernette J. Molloy,Douglas R. Mackintosh

October 1st 2004

Applied Clinical Trials

A new reference guide clarifies uncertainty surrounding this sometimes misunderstood document.

Latest Updated Articles

A Closer Look at 1572: Interpreting the FDA's Statement of Investigator Form
September 1st 2010
A Closer Look at the 1572: Interpreting the FDA's Statement of Investigator Form
October 1st 2004

Trending on Applied Clinical Trials Online

ICON Selects Microsoft as Preferred Technology Partner to Scale Agentic AI Platform Across Clinical Trial Lifecycle

ACT Brief: ICON-Microsoft AI Partnership, DCT Site Burden, and AI-Enabled Neuroimmune Discovery

HHS Launches Operation TrialBlazer to Restore US Leadership in Clinical Research

ACT Brief: Mixed FSP Strategy, DIA Meeting Trends, and Patient Voice in Oncology

ACT Brief: Real-Time Evidence Generation, Protocol Digitization, and Decentralized Trial Flexibility